Search clinical trials for: Interleukin-26

Total 917 results

Stanford University

Terminated

Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain

Pain | Inflammation

United States
University Hospital, Basel, Switzerland

Completed

Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome (TestIL)

Obesity | Hypogonadism | Metabolic Syndrome X

Switzerland
Radboud University Medical Center

Completed

Cytokine Inhibition in Chronic Fatigue Syndrome Patients (CiCFS)

Chronic Fatigue Syndrome

Netherlands
Virginia Commonwealth University
American Heart Association

Completed

Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)

Heart Failure

United States
M.D. Anderson Cancer Center
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients

Leukemia | Chronic Myeloid Leukemia | Chronic Myelogenous Leukemia

United States
Amgen

Terminated

The SPECTRA Study

Rheumatoid Arthritis
Amgen

Completed

Treatment for Patients With Osteoarthritis (OA) of the Knee

Osteoarthritis
Hellenic Institute for the Study of Sepsis

Active, not recruiting

Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia (INSPIRE)

Hospital-acquired Pneumonia | Community-acquired Pneumonia

Greece
Charite University, Berlin, Germany
Max Planck Institute for Infection Biology

Completed

Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS)

Germany
Hamad Medical Corporation

Completed

Anakinra in the Management of COVID-19 Infection

Pneumonia | Covid19 | Corona Virus Infection | Cytokine Release Syndrome | Viral Infection

Qatar
Adel Helmy
Cambridge University Hospitals NHS Foundation Trust

Unknown

IL-1ra Dose-range Study for Moderate-to-severe TBI Patients (IL1ra)

Traumatic Brain INjury

United Kingdom
Virginia Commonwealth University
American Heart Association

Completed

Anakinra to Prevent Adverse Post-infarction Remodeling (2) (VCU-ART2)

Heart Failure | Acute Myocardial Infarction

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Melanoma (Skin)

United States
Loma Linda University

Terminated

Adjunctive Hydrogen Peroxide for Periodontal Therapy (AHP)

Periodontitis, Chronic

United States
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Chemotherapy-induced Thrombocytopenia

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Reza Dana, MD

Terminated

Topical IL-1-Ra for Treatment of Corneal Neovascularization

Corneal Neovascularization

United States
National Institute of Allergy and Infectious Diseases...
Chiron Corporation

Completed

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy (ESPRIT)

HIV Infections

United States, Brazil, Australia, Argentina, Austria, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Morocco, Netherlands, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

Chronic Graft Versus Host Disease

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
Centre Hospitalier St Anne
For Drug Consulting

Recruiting

Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD (IL-2-AD)

Alzheimer Disease

France
Providence Health & Services
Prometheus Laboratories

Active, not recruiting

Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. (SBRT/IL-2)

Metastatic Melanoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Leukemia

United States, Switzerland, Canada, Netherlands, Puerto Rico, Australia
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (ILIADE)

HIV Infections

United States, France
Abramson Cancer Center of the University of Pennsylvania

Withdrawn

A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ovarian, Fallopian Tube and Peritoneal Cancer

United States
Instituto Jalisciense de Cancerologia
University of Guadalajara; Instituto Mexicano del Seguro Social

Unknown

Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis. (WESTEMDRB1)

Multiple Sclerosis, Relapsing-Remitting

Mexico
Beijing YouAn Hospital

Unknown

Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC

Hepatocellular Carcinoma

China
NYU Langone Health
National Cancer Institute (NCI)

Completed

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

Head and Neck Cancer
Dana-Farber Cancer Institute
ImmunityBio, Inc.; Kidney Cancer Association

Not yet recruiting

Memory-like Natural Killer (NK) Cell Therapy With N-803 in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Renal Cell Carcinoma | Urothelial Carcinoma | Renal Carcinoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

HIV Infections | Sarcoma, Kaposi

United States
University of Athens

Completed

Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease

Coronary Artery Disease | Inflammation | Rheumatoid Arthritis

Greece
University Health Network, Toronto

Completed

Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma

Metastatic, Stage III or Stage IV, Melanoma

Canada
National Cancer Institute (NCI)

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
National Cancer Institute (NCI)

Completed

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Recurrent Melanoma | Stage IV Melanoma

United States
Assistance Publique - Hôpitaux de Paris

Completed

Anakinra Versus Placebo for the Treatment of Acute MyocarditIS (ARAMIS)

Acute Myocarditis

France
Weill Medical College of Cornell University
Swedish Orphan Biovitrum

Withdrawn

Anakinra, COVID-19, Cytokine Storm (SOBI)

Covid19 | Mechanical Ventilation Complication | Cytokine Storm

United States
Second Xiangya Hospital of Central South University

Recruiting

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

Pemphigus Vulgaris

China
Cambridge University Hospitals NHS Foundation Trust

Completed

Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY (IVORY)

Acute Coronary Syndromes

United Kingdom
Sahlgrenska University Hospital, Sweden

Not yet recruiting

Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer (PANCEP-1)

Pancreatic Cancer | Surgery | Metastasis | Immunosuppression
Emory University
National Cancer Institute (NCI)

Recruiting

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8

United States
Sumithira Vasu

Completed

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Inge Marie Svane

Completed

T-cell Based Immunotherapy for of Melanoma

Melanoma

Denmark
National Cancer Institute (NCI)

Completed

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Recurrent Endometrial Carcinoma | Male Breast Cancer | Recurrent Small Cell Lung Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Gastric Cancer | Recurrent Non-small Cell Lung Cancer

United States
Inge Marie Svane

Withdrawn

T-cell Based Immunotherapy for Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Carcinoma

Denmark
Hellenic Institute for the Study of Sepsis

Recruiting

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome (PRECISION)

Long COVID | Post-Acute COVID-19 | Post-Acute COVID-19 Syndrome

Germany, Greece, Italy, Spain
Wake Forest University Health Sciences
Emory University

Completed

A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas (Poly-ICLC)

Brain Tumors

United States
University Hospital, Caen
University Hospital, Rouen; Central Hospital Saint Quentin; University Hospital... and other collaborators

Unknown

Giant Cell Arteritis and Anakinra Trial (GiAnT)

Giant Cell Arteritis

France
Prof. Roberto Giacomelli

Terminated

Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes (TRACK)

Diabetes Mellitus, Type 2 | Arthritis, Rheumatoid

Italy
National Cancer Institute (NCI)

Completed

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma

United States
Swedish Orphan Biovitrum

Terminated

Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.

SARS-CoV-2

United States, Italy

Search clinical trials for: Interleukin-26

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations